miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo

被引:53
作者
Chen, Cheng-long [1 ]
Zhang, Long [2 ]
Jiao, Yu-rui [1 ]
Zhou, Yi [3 ]
Ge, Qiao-feng [1 ]
Li, Peng-cui [4 ]
Sun, Xiao-juan [4 ]
Lv, Zhi [2 ]
机构
[1] Shanxi Med Univ, Clin Med Coll 2, Taiyuan, Shanxi, Peoples R China
[2] Shanxi Med Univ, Hosp 2, Dept Orthopaed, 382 Wuyi Rd, Taiyuan 030001, Shanxi, Peoples R China
[3] Southern Med Univ, Clin Med Sch 1, Guangzhou, Guangdong, Peoples R China
[4] Shanxi Med Univ, Hosp 1, Shanxi Key Lab Bone & Soft Tissue Injury Repair, 382 Wuyi Rd, Taiyuan 030001, Shanxi, Peoples R China
关键词
invasion; matrix metalloproteinases; metastasis; miR-134; osteosarcoma; EXTRACELLULAR-MATRIX; DECREASED EXPRESSION; TISSUE INHIBITOR; TUMOR; GENE; METALLOPROTEINASES; MIGRATION; ASSOCIATION; BIOGENESIS; PROGNOSIS;
D O I
10.1002/1873-3468.13387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
miR-134 has been shown to be associated with angiogenesis and the progression of osteosarcoma. This study further assessed the effects of miR-134 expression on osteosarcoma cell migration, invasion, and metastasis in vitro and in a nude mouse xenograft model, exploring the underlying molecular events. Luciferase reporter assays revealed that miR-134 directly targets the 3 '-UTRs of MMP1 and MMP3 to reduce their expression in osteosarcoma cells. In conclusion, overexpression of miR-134 suppresses osteosarcoma cell invasion and metastasis through the inhibition of MMP1 and MMP3 expression. We propose miR-134 as an attractive novel therapeutic target for the treatment of osteosarcoma.
引用
收藏
页码:1089 / 1101
页数:13
相关论文
共 59 条
[1]  
Adiguzel M, 2016, INDIAN J EXP BIOL, V54, P175
[2]   Update on Survival in Osteosarcoma [J].
Anderson, Megan E. .
ORTHOPEDIC CLINICS OF NORTH AMERICA, 2016, 47 (01) :283-+
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma [J].
Berend, KR ;
Toth, AP ;
Harrelson, JM ;
Layfield, LJ ;
Hey, LA ;
Scully, SP .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (01) :11-17
[5]   Remodelling the extracellular matrix in development and disease [J].
Bonnans, Caroline ;
Chou, Jonathan ;
Werb, Zena .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (12) :786-801
[6]   Cancer stem cells in osteosarcoma [J].
Brown, Hannah K. ;
Tellez-Gabriel, Marta ;
Heymann, Dominique .
CANCER LETTERS, 2017, 386 :189-195
[7]   Tumor and its microenvironment: A synergistic interplay [J].
Catalano, Veronica ;
Turdo, Alice ;
Di Franco, Simone ;
Dieli, Francesco ;
Todaro, Matilde ;
Stassi, Giorgio .
SEMINARS IN CANCER BIOLOGY, 2013, 23 (06) :522-532
[8]   Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions [J].
Deryugina, Elena I. ;
Quigley, James P. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (01) :103-120
[9]   Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis [J].
Estep, Michael ;
Mehta, Rohini ;
Bratthauer, Gary ;
Alaparthi, Lakshmi ;
Monge, Fanny ;
Ali, Simon ;
Abdelatif, Dinan ;
Younoszai, Zahra ;
Stepanova, Maria ;
Goodman, Zachary D. ;
Younossi, Zobair M. .
BMC GASTROENTEROLOGY, 2019, 19 (1)
[10]   Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma - Findings in 42 patients followed for 1-16 years [J].
Ferrari, C ;
Benassi, MS ;
Ponticelli, F ;
Gamberi, G ;
Ragazzini, P ;
Pazzaglia, L ;
Balladelli, A ;
Bertoni, F ;
Picci, P .
ACTA ORTHOPAEDICA SCANDINAVICA, 2004, 75 (04) :487-491